Autogramin-1

CAS No. 2375541-73-2

Autogramin-1( —— )

Catalog No. M26065 CAS No. 2375541-73-2

Autogramin-1 potently inhibits starvation-induced autophagy with IC50 of 0.17 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 334 In Stock
10MG 468 In Stock
25MG 730 In Stock
50MG 918 In Stock
100MG 1293 In Stock
200MG Get Quote In Stock
500MG 2595 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Autogramin-1
  • Note
    Research use only, not for human use.
  • Brief Description
    Autogramin-1 potently inhibits starvation-induced autophagy with IC50 of 0.17 μM.
  • Description
    Autogramin-1 potently inhibits starvation-induced autophagy with IC50 of 0.17 μM. Autogramin-1 also inhibits Rapamycin (mTORC1)-induced autophagy with IC50 of 0.44 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    mTOR
  • Recptor
    P2X3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2375541-73-2
  • Formula Weight
    485.56
  • Molecular Formula
    C23H27N5O5S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 6.94 mg/mL (14.29 mM)
  • SMILES
    CCCn1c(=O)[nH]c2cc(ccc2c1=O)C(=O)Nc1nc2CCN(Cc2s1)C(=O)OC(C)(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Spinaci A, et, al. P2X3 Receptor Ligands: Structural Features and Potential Therapeutic Applications. Front Pharmacol. 2021 Apr 13;12:653561.
molnova catalog
related products
  • Y16

    Y16 is a G-protein–coupled Rho GEFs inhibitor; works synergistically with Rhosin/G04 in inhibiting LARG-RhoA interaction, RhoA activation, and RhoA-mediated signaling functions.

  • JR-AB2-011

    JR-AB2-011 inhibits mTORC2 activity by blocking Rictor-mTOR association (Ki: 0.19 μM). JR-AB2-011 has anti-glioblastoma multiforme (GBM) properties.

  • PP 242

    A potent, specific active-site inhibitor of mTOR with IC50 of 30 and 58 nM for mTORC1 and mTORC2, respectively.